ANTHEIA
Antheia is a biotechnology company unlocking the medicinal power of nature with its rapid response biomanufacturing processes for essential medicines. Antheia uses synthetic biology to surpass the limits of conventional drug manufacturing and discovery. By reconstructing complex molecules in yeast, Antheia can produce APIs without the use of medicinal plants, transforming the pharmaceutical supply chain and ensuring reliable, consistent, and widespread availability to essential medicines.
ANTHEIA
Industry:
Biotechnology Health Care Manufacturing
Founded:
2015-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.antheia.bio
Total Employee:
11+
Status:
Active
Contact:
650-353-5191
Email Addresses:
[email protected]
Total Funding:
152.1 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Font Awesome
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Medtrica
Medtrica is a medical manufacturing company with operations facilities located in Langley, British Columbia.
Mindstate Design Labs
Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics.
Retainer Club
Retainer Club is a subscription healthcare business that manufactures 3-D printed custom retainers, mouth guards and night guards.
Current Employees Featured
Founder
Investors List
Viking Global Investors
Viking Global Investors investment in Venture Round - Antheia
BioMaP-Consortium
BioMaP-Consortium investment in Grant - Antheia
Echo Investment Capital
Echo Investment Capital investment in Venture Round - Antheia
In-Q-Tel
In-Q-Tel investment in Venture Round - Antheia
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Antheia
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Antheia
Hillspire
Hillspire investment in Series B - Antheia
Viking Global Investors
Viking Global Investors investment in Series B - Antheia
Irregular Expressions
Irregular Expressions investment in Series B - Antheia
Sherpalo Ventures
Sherpalo Ventures investment in Series B - Antheia
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-18 | Antheia Appoints Zack McGahey as Chief Operating Officer |
Official Site Inspections
http://www.antheia.bio Semrush global rank: 4.2 M Semrush visits lastest month: 2.39 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Antheia"
About Us - Antheia
The World Health Organization estimates over two billion people worldwide lack access to basic medicines. ... Antheia incorporates and raises Seed financing round. The Smolke Lab also …See details»
Platform - Antheia
Farrah leads program and project management at Antheia. She has over 20 years of experience leading program and project management, operations, and engineering for companies across …See details»
Antheia - Crunchbase Company Profile & Funding
Antheia is a biotechnology company unlocking the medicinal power of nature with its rapid response biomanufacturing processes for essential medicines. Antheia uses synthetic biology to surpass the limits of conventional drug …See details»
Antheia, Inc. - LinkedIn
Antheia, Inc. Biotechnology Research Menlo Park, California 7,359 followers A synthetic biology company unlocking the medicinal power of nature - a platform for drug discovery and manufacturingSee details»
Female-Founded Antheia Raises $73 Million to Support ... - BioSpace
Jun 30, 2021 Synthetic biology startup Antheia raised $73 million in Series B financing to support the company’s efforts to bring its first plant-based medicine to market and support the …See details»
Antheia Achieves Major Commercial Milestone - PR Newswire
Aug 24, 2023 Antheia's pipeline aligns with the U.S. Food and Drug Administration and the World Health Organization's Essential Medicines lists and the company's platform supports …See details»
Antheia Company Profile 2024: Valuation, Funding
Antheia General Information Description. Operator of a biotechnology company intended to develop plant-inspired medicines. The company's cost-competitive, plant-based medicines are made using synthetic biology, informatics, and …See details»
Antheia: Contact Details, Revenue, Funding, Employees and …
Antheia is transforming pharmaceutical supply chains by using synthetic biology to engineer complex molecules in yeast, enabling the development of plant-inspired medicines. This …See details»
Antheia’s Monumental Commercial Achievement - SynBioBeta
Aug 24, 2023 What stands out is the synchronicity of Antheia’s pipeline with recognized entities like the U.S. Food and Drug Administration and the World Health Organization’s Essential …See details»
Antheia Announces $73M Series B to Commercialize Synthetic
Jun 30, 2021 "Antheia is leading innovation in synthetic biology, and its platform can bring about significant improvements in production time, scale, and cost for our most essential plant …See details»
Antheia Completes Successful Product Validation - Yahoo Finance
Antheia (PRNewsfoto/Antheia) "Achieving process validation with a novel bio-based process in just one year is phenomenal and speaks volumes to the technical capabilities of our R&D and …See details»
Antheia and Olon Continue Partnership for Biomanufacturing …
Mar 13, 2024 Menlo Park, CA and Milan, Italy – March 13, 2024 – Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains and Olon Group, the …See details»
Accelerating Production of Essential Medicines with Antheia
Aug 12, 2021 Partnership enables Antheia to broaden its pipeline of critical active pharmaceutical ingredients and key starting materials Nearly half of all medicines today are …See details»
Antheia and Ginkgo Bioworks Announce Partnership to Accelerate ...
Aug 12, 2021 “Antheia is committed to using synthetic biology to enable more equitable access to essential medicines,” said Kristy Hawkins, CSO and co-founder at Antheia. “By partnering …See details»
Synthetic bio company Antheia raises $40m, announces pilot plant
Aug 31, 2022 Thanks to $40m USD in financing from a number of investors, synthetic biology company Antheia is poised to make its plans for a pilot-scale manufacturing facility a reality. …See details»
Antheia Announces $73M Series B to Commercialize Synthetic …
Jun 30, 2021 Antheia's team of scientists and technologists is headquartered in Menlo Park, California. For more information, visit www.antheia.bio . CONTACT: Mission North for Antheia, …See details»
Antheia's 2022 in Review: A Year of Value - Antheia
Dec 8, 2022 Antheia strives to be a leader in transparent and transformative essential medicine production. The following are our guiding principles – the value-based beliefs we hold as …See details»
Antheia Company Profile - Office Locations, Competitors ... - Craft
Antheia is a science and technology company developing plant-inspired medicines. Applying synthetic biology, genomics, informatics, and fermentation, the company uses beneficial …See details»
Antheia Announces $73M Series B to Commercialize Synthetic …
Jun 30, 2021 Led by Viking Global Investors, the Series B round will be used to bring Antheia’s first pharmaceutical compounds to market, expand its pipeline and scale production in global …See details»